Randomized and open-label clinical trials of human botulism immune globulin intravenous for the treatment of infant botulism.

被引：0
|
作者：
Arnon, SS
Schechter, R
Maslanka, S
Hatheway, CL
机构：
[1] Calif Dept Hlth Serv, Berkeley, CA 94704 USA
[2] Ctr Dis Control & Prevent, Atlanta, GA USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2005年 / 53卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
436
引用
收藏
页码：S154 / S154
页数：1
相关论文
共 50 条
  • [1] Human botulism immune globulin for the treatment of infant botulism
    Arnon, SS
    Schechter, R
    Maslanka, SE
    Jewell, NP
    Hatheway, CL
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (05): : 462 - 471
  • [2] CLINICAL-TRIAL OF BOTULISM IMMUNE GLOBULIN FOR INFANT BOTULISM
    FRANKOVICH, TL
    ARNON, SS
    WESTERN JOURNAL OF MEDICINE, 1991, 154 (01): : 103 - 103
  • [3] Efficacy of Human Botulism Immune Globulin for the Treatment of Infant Botulism: The First 12 Years Post Licensure
    Payne, Jessica R.
    Khouri, Jessica M.
    Jewell, Nicholas P.
    Arnon, Stephen S.
    JOURNAL OF PEDIATRICS, 2018, 193 : 172 - 177
  • [4] Human botulism immune globulin for the treatment of infant botulism: The first four years post-licensure
    Arnon, Stephen S.
    Payne, J. R.
    Drummond, Y.
    Barash, J. R.
    TOXICON, 2008, 51 : 8 - 9
  • [5] Infant botulism: A 30-year experience spanning the introduction of botulism immune globulin intravenous in the intensive care unit at Childrens Hospital Los Angeles
    Underwood, Karen
    Rubin, Sarah
    Deakers, Timothy
    Newth, Christopher
    PEDIATRICS, 2007, 120 (06) : E1380 - E1385
  • [6] Comparison between IV immune globulin (IVIG) and anti-D globulin for treatment of immune thrombocytopenia: a randomized open-label study
    Eghbali, Aziz
    Azadmanesh, Peyman
    Bagheri, Bahador
    Taherahmadi, Hasan
    Sedeh, Bahman Sadeghi
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 (04) : 385 - 389
  • [7] DEVELOPMENT OF INFANT BOTULISM IN A 3-YEAR-OLD FEMALE WITH NEUROBLASTOMA FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION - POTENTIAL USE OF HUMAN BOTULISM IMMUNE GLOBULIN
    SHEN, WPV
    FELSING, N
    LANG, D
    GOODMAN, G
    CAIRO, MS
    BONE MARROW TRANSPLANTATION, 1994, 13 (03) : 345 - 347
  • [8] Considerations for open-label randomized clinical trials: Design, conduct, and analysis
    Higgins, Karen M.
    Levin, Gregory
    Busch, Robert
    CLINICAL TRIALS, 2024, 21 (06) : 681 - 688
  • [9] A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients
    Davis, GL
    Nelson, DR
    Terrault, N
    Pruett, TL
    Schiano, TD
    Fletcher, CV
    Sapan, CV
    Riser, LN
    Li, YF
    Whitley, RJ
    Gnann, JW
    LIVER TRANSPLANTATION, 2005, 11 (08) : 941 - 949
  • [10] An open-label clinical study of nitazoxanide in the treatment of human fascioliasis
    Kabil, SM
    El Ashry, E
    Ashraf, NK
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2000, 61 (06): : 339 - 345
12345